Aptose Biosciences
APTO
#10464
Rank
HK$33.95 M
Marketcap
HK$13.30
Share price
0.00%
Change (1 day)
755.03%
Change (1 year)

Aptose Biosciences (APTO) - Total liabilities

Total liabilities on the balance sheet as of March 2025 : HK$0.11 Billion

According to Aptose Biosciences's latest financial reports the company's total liabilities are HK$0.11 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Aptose Biosciences - Total liabilities on balance sheet (from 2001 to 2025)

Total liabilities by year

Year Total liabilities Change
2023-12-31HK$0.12 B19.55%
2022-12-31HK$0.10 B60.61%
2021-12-31HK$64.63 M13.48%
2020-12-31HK$56.95 M11.65%
2019-12-31HK$51.01 M133.57%
2018-12-31HK$21.84 M58.38%
2017-12-31HK$13.78 M34.92%
2016-12-31HK$10.22 M-22.52%
2015-12-31HK$13.19 M
2014-05-31HK$17.57 M28.5%
2013-05-31HK$13.67 M-32.64%
2012-05-31HK$20.3 M120.09%
2011-05-31HK$9.22 M-56.07%
2010-05-31HK$21 M-81.4%
2009-05-31HK$0.11 B-6.95%
2008-05-31HK$0.12 B15.88%
2007-05-31HK$0.10 B6.02%
2006-05-31HK$98.75 M11.35%
2005-05-31HK$88.68 M166.11%
2004-05-31HK$33.32 M9.43%
2003-05-31HK$30.45 M73.9%
2002-05-31HK$17.51 M-41.13%
2001-05-31HK$29.74 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Advaxis
ADXS
HK$0.31 B 175.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Corbus Pharmaceuticals
CRBP
HK$0.10 B-5.15%๐Ÿ‡บ๐Ÿ‡ธ USA
ImmunoGen
IMGN
HK$2.02 B 1,653.06%๐Ÿ‡บ๐Ÿ‡ธ USA